RIZATRIPTAN AH rizatriptan (as benzoate) 10 mg orally disintegrating tablets blisters

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

rizatriptan benzoate

Zāļu forma:

Tablet, orally disintegrating

Kompozīcija:

Excipient Ingredients: acesulfame potassium; ethylcellulose; silicon dioxide; mannitol; crospovidone; hypromellose; sodium stearylfumarate; colloidal anhydrous silica; Flavour

Ievadīšanas:

Sublingual

Vienības iepakojumā:

3, 2, 6, 1

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

for acute treatment of migraine attacks with or without aura.

Produktu pārskats:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-03-20